BIOCHEMICAL SCREENING OF MARINE MICROMONOSPORA MARINA KPMS1 (MH036351) AND ITS ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT BACTERIA

  • MOHAMED MAHROOP RAJA M Department of Microbiology, Jamal Mohamed College (Autonomous), Tiruchirappalli ‑ 620 020, Tamil Nadu, India.
  • RAJA A Department of Microbiology, Jamal Mohamed College (Autonomous), Tiruchirappalli ‑ 620 020, Tamil Nadu, India.
  • REEHANA N Department of Microbiology, Jamal Mohamed College (Autonomous), Tiruchirappalli ‑ 620 020, Tamil Nadu, India.

Abstract

Objective: The present investigation aimed at the screening of pharmaceutically potential antimicrobial metabolite isolated from marine Micromonospora sp. to combat the multidrug‑resistant bacteria.


Materials and Methods: The Marine sediments were randomly collected for the isolation of Micromonospora sp., from Gulf of Mannar, East Coastal Region, located at Kayalpatnam, Tuticorin district, Tamil Nadu, India. The Micromonospora sp. was cultivated by serial dilution and crowed plating method on actinomycetes isolation agar. The isolated colonies were identified by morphological, cultural, and biochemical methods. The antibacterial study of Micromonospora sp. was performed on Mueller‑Hinton agar medium against multidrug‑resistant bacteria isolated from urinary tract infection. The antibacterial compound was separated and characterized by Fourier‑transform infrared (FT‑IR) and nuclear magnetic resonance (NMR) spectrum.


Results: Based on the morphological, cultural, and biochemical studies, the isolated colonies were found to be the genera of Micromonospora. Among Micromonospora genera, Micromonospora marina KPMS1 strain showed potent antibacterial activity against multidrug‑resistant Escherichia coli, Pseudomonas aeruginosa, and Enterococcus faecalis. The FT‑IR and NMR studies showed the structural elucidation of active compounds derived from M. marina KPMS1. The 16S rRNA sequences of M. marina KPMS1 (MH036351) strain were blasted and deposited in the GenBank of National Center for Biotechnology Information.


Conclusion: The results of the study were concluded that microbial compounds are the promising sources of nearly all of the antibiotics produced by marine Micromonospora sp. The detection of new biological compounds was considered to represent a novel species of the genus Micromonospora which have been used for clinical treatment against multidrug‑resistant bacteria and were pharmaceutically important.

Keywords: Biochemical studies, 16S rRNA sequences, Antimicrobial, Antibiotics, Multidrug‑resistant bacteria.

Author Biographies

MOHAMED MAHROOP RAJA M, Department of Microbiology, Jamal Mohamed College (Autonomous), Tiruchirappalli ‑ 620 020, Tamil Nadu, India.

PG & Research Department of Microbiology

RAJA A, Department of Microbiology, Jamal Mohamed College (Autonomous), Tiruchirappalli ‑ 620 020, Tamil Nadu, India.

PG & Research Department of Microbiology

REEHANA N, Department of Microbiology, Jamal Mohamed College (Autonomous), Tiruchirappalli ‑ 620 020, Tamil Nadu, India.

PG & Research Department of Microbiology

References

1. Zhao H, Kassama Y, Young M, Kell DB, Goodacre R. Differentiation of Micromonospora isolates from a coastal sediment in wales on the basis of fourier transform infrared spectroscopy, 16S rRNA sequence analysis, and the amplified fragment length polymorphism technique. Appl Environ Microbiol 2004;70:6619 27.
2. Genilloud O. Genus micromonospora ørskov 1923, 156AL. In: Bergey’s Manual of Systematic Bacteriology. Vol. 5. New York: Springer; 2012. p. 1039 57.
3. Tanasupawat S, Jongrungruangchok S, Kudo T. Micromonospora marina sp. Nov. isolated from sea sand. Int J Syst Evol Microbiol 2010;60:648 52.
4. Supong K, Suriyachadkun C, Pittayakhajonwut P, Suwanborirux K, Thawai C. Micromonospora spongicola sp. Nov. an actinomycete isolated from a marine sponge in the Gulf of Thailand. J Antibiot (Tokyo) 2013;66:505 9.
5. Fenical W, Jensen PR. Developing a new resource for drug discovery: Marine actinomycete bacteria. Nat Chem Biol 2006;2:666 73.
6. Chambers HF. General principles of antimicrobial therapy. In: Brunton LL, Lazo J, Parker K, editors. Goodman and Gilman’s Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw Hill; 2006. p. 1095 111.
7. Bérdy J. Bioactive microbial metabolites. J Antibiot (Tokyo) 2005;58:1 26.
8. Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR. Marine natural products. Nat Prod Rep 2012;29:144 222.
9. Pathom aree W, Stach JE, Ward AC, Horikoshi K, Bull AT, Goodfellow M. Diversity of actinomycetes isolated from challenger deep sediment (10.898M) from the Mariana trench. Extremophiles 2006;10:181 9.
10. Abbas IH. A biological and biochemical studies of actinomycetes isolated from Kuwait saline soil Kuwait. J Appl Sci Res 2006;2:809 15.
11. Savitri NA, Astana N, Azmi W. Microbial lasparagenase: A potent anti tumor enzyme. Indian J Biotechnol 2003;2:184 94.
12. Laidi RF, Kansoh AL, Elshafei AM, Cheikh B. Taxonomy, identification and biological activities of novel isolate of Streptomyces tendae. Arab J Biotechnol 2006;9:427 36.
13. Sharma D, Kaur T, Chadha BS, Manhas RK. Antimicrobial activity of actinomycetes against multidrug resistant Staphylococcus aureus, E. coli and various other pathogens. Trop J Pharm Res 2011;10:801 8.
14. Subramani R, Aalbersberg W. Culturable rare actinomycetes: Diversity, isolation and marine natural product discovery. Appl Microbiol Biotechnol 2013;97:9291 321.
15. Tiwari K, Dilip JU, Eva M, Roderich S, Rajinder KG. Culturable bioactive actinomycetes from the great Indian Thar desert. Ann Microbiol 2015;65:1901 14.
16. Bérdy J. Thoughts and facts about antibiotics: Where we are now and where we are heading. J Antibiot (Tokyo) 2012;65:385 95.
17. Sánchez López JM, Martínez Insua M, Pérez Baz J, Fernández Puentes JL, Cañedo Hernández LM. New cytotoxic indolic metabolites from a marine Streptomyces. J Nat Prod 2003;66:863 4.
18. Nagaseshu P, Gayatridevi V, Kumar BA, Kumari S, Mohan GM, Malla RR. Antioxidant and antiproliferative potentials of marine actinomycetes. Int J Pharm Pharm Sci 2016;8:277 84.
19. Sallam LA, El Refai AF, Osman ME, Hamdy AA, Ahmed EM, Mohamed MA. Some physiological factors affecting rapamycin production by Streptomyces hygroscopicus ATCC 29253. J Am Sci 2010;6:188 94.
20. Sarquis MI, Oliveira EM, Santos AS, Costa GL. Production of L asparaginase by filamentous fungi. Mem Inst Oswaldo Cruz 2004;99:489 92.
21. Kokare CR, Mahadik KR, Kadam SS, Chopade BA. Isolation, characterization and antimicrobial activity of marine halophilic Actinopolyspora species AH1 from the West coast of India. Curr Sci 2004;86:593 7.
22. Sibanda T, Mabinya LV, Mazomba N, Akinpelu DA, Bernard K, Olaniran AO, et al. Antibiotic producing potentials of three freshwater actinomycetes isolated from the Eastern Cape province of South Africa. Int J Mol Sci 2010;11:2612 23.
23. Tiwari K, Gupta RK. Rare actinomycetes: A potential storehouse for novel antibiotics. Crit Rev Biotechnol 2012;32:108 32.
24. Janardhan A, Kumar AP, Viswanath B, Saigopal DV, Narasimha G. Production of bioactive compounds by actinomycetes and their antioxidant properties. Biotechnol Res Int 2014;2014:217030.
25. Sheik GB, Maqbul MS, Shankar SG, Ranjith MS. Isolation and characterization of actinomycetes from soil of ad dawadmi, Saudi Arabia and screening their antibacterial activities. Int J Pharm Pharm Sci 2017;9:276 9.
26. Ravikumar S, Fredimoses FM, Gokulakrishnan R. Biodiversity of actinomycetes in Manakkudi mangrove ecosystem, South West coast of Tamil Nadu, India. Ann Biol Res 2011;2:76 82.
27. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S, et al. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011;28:2731 9.
28. Nei M, Kumar S. Molecular Evolution and Phylogenetics. New York: Oxford University Press; 2000.
Statistics
11 Views | 34 Downloads
How to Cite
M, M. M. R., R. A, and R. N. “BIOCHEMICAL SCREENING OF MARINE MICROMONOSPORA MARINA KPMS1 (MH036351) AND ITS ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT BACTERIA”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 2, Jan. 2019, pp. 405-10, https://innovareacademics.in/journals/index.php/ajpcr/article/view/29872.
Section
Original Article(s)